Biotech · Private company
Opiant Pharmaceuticals Inc
Track this companyFree. Adds Opiant Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- NalmefenePhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- Nalmefene hydrochloridePhase 1 · PharmacodynamicClinicalTrials.gov · fetched Nov 12, 2026
- Nalmefene HydrochloridePhase 1 · Opioid OverdoseClinicalTrials.gov · fetched Nov 12, 2026
- Nalmefene HydrochloridePhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- Naloxone hydrochloridePhase 1 · PharmacodynamicClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing RegimensPHASE1 · COMPLETED · started Sep 1, 2021ClinicalTrials.gov NCT05219669 · fetched Nov 12, 2026
- Pharmacodynamic Evaluation of Intranasal NalmefenePHASE1 · COMPLETED · started Mar 30, 2021ClinicalTrials.gov NCT04828005 · fetched Nov 12, 2026
- Pharmacokinetic Evaluation of Intranasal NalmefenePHASE1 · COMPLETED · started Feb 8, 2021ClinicalTrials.gov NCT04759768 · fetched Nov 12, 2026